Is Filana Therapeutics, Inc. overvalued?

Filana Therapeutics, Inc. (FLNA) — key valuation metrics and fundamentals.

No verdict

Price

$0.43

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$20.5M

Dividend yield

0.0%

Return on equity

-63.9%

Sector

Healthcare

Fair value compares FLNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks